Adenosquarnous carcinoma of the uterine cervix - adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report

Adenosquamous carcinoma of the uterine cervix is a rare mixture of malignant glandular and squamous epithelial elements. We present a case of a 56-year-old woman with Stage IV cervical carcinoma treated with paclitaxel and carboplatin chemotherapy after cytoreductive surgery. Solitary liver metastases were treated by ultrasound guided percutaneous sclerotherapy with 95% ethanol. For ten months the patient showed an objective response to the treatment with a good quality of life during that time. A year after the first, the second cytoreductive operation was performed and chemotherapy (paclitaxel, carboplatin, and epirubicin) followed. The patient died 20 months after establishing the diagnosis. Paclitaxel in combination with carboplatin as adjuvant chemotherapeutic treatment could be another promising agent for patients with advanced metastatic cervical adenocarcinoma.

Cervical adenosquamous cancer; Adjuvant chemotherapy; Paclitaxel, Carboplatin

[1] Tattersall M., Ramirez C., Coopleson M.: "A randomised trial of adjuvant chemotherapy after radical hysterectomy in stage lb-Ila cervical cancer patients with pelvic lymph node metastasis" Gynecol. Oncol., 1992, 46, 176.

[2] Napolitano C., Imperato F., Mossa B., Framarino M.L, Marziam R., Marzetti L.: "The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomised trial". Eur. J. Gynaecol. Oncol., 2003, 24, 51.

[3] Peru E., Benedicic Ch., Seewann A., Pickel H.: "Palliative cytostatic treatment of cervical carcinoma". Eur. J Gynecol Oncol., 2003, 24, 473.

[4] Moore D.H., Blessing J.A., McQuellon R.P., Thaler H.T., Cella D., Benda J. et al.: "Phase III study of cisplatin with or without paclitaxel in Stage !VB, recurrent or persistent squamous cell carcinoma of the cervix: A Gynaecologic Oncology Group study". J. Clin. Oncol., 2004, 1, 22, 3113.

[5] McGuire W.P., Blessing J.A., Moore D.: "Paclitaxel has moderate activity in squamous cervix cancer: A Gynecologic Oncology Group study". J. Clin. Oncol., 1996, 14, 792.

[6] Kudelka A.P., Winn R., Edvards C.L.: "Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix". Clin. Cancer Res., 1996, 2, 1285.

[7] Curtin P.C., Blessing J.A., Webster K.D., Rose P.O., Mayer A.R., Fowler J.H. et al.: "Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: A Gynecologic Oncology Group study". Clin. Oncol., 2001, 19, 1275.

[8] Tabata T., Nishiura K., Yanoh K., Okugawa T., Obata H., Tanaka K., Toyoda N.: "A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix". Int J Clin Oncol., 2004, 9, 59.

[9] Saito T., Takehara M., Lee R., Fujimoto T., Nishimura M., Tanaka R. et al.: "Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma-a preliminary study". int. J. Gynecol. Cancer, 2004, 14, 483.

[10] Agrawal M., Edgerly M., Fojo T., Kotz H.: "Treatment of recurrent cervical adenocarcinoma with BMS-247550, a epothilone B analog". Gynecol. Oncol., 2003, 90, 96.

[11] Park D.C., Kim J.H., Lew YO., Namkoong S.E.: "Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervix cancer" Gynaecol. Oncol., 2004, 92, 59.

[12] Pignut S., Freeze P., Tramontana S., Perrone F., Trambaro R., Casella C. et al.: "Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri". Ann. Oncol., 2000, ll, 455.

[13] Ota S., Sugiyama T., Ushijama K., Komai K., Hirai N., Nishida T et al.: "Remission of metastatic cervical adenocarcinoma with weekly paclitaxel". Int. J Gynecol. Cancer, 2001, 11, 167.

[14] Sit A.S., Kelley J.L., Gallion H.H., Kunschner A.J., Edwards R.P "Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix". Cancer Invest., 2004, 22, 368.